---
title: "Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025"
date: "2025-02-07 22:15:02"
summary: "Avantor&#39;s Q4 net sales missed estimates, but adjusted EPS beat expectations. The company projects 2025 organic revenue growth and stronger free cash flow."
categories:
  - "benzinga"
lang:
  - "en"
translations:
  - "en"
tags:
  - "benzinga"
menu: ""
thumbnail: "https://www.benzinga.com/files/images/story/2025/02/07/AVTR.png"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Avantor's Q4 net sales missed estimates, but adjusted EPS beat expectations. The company projects 2025 organic revenue growth and stronger free cash flow.

[benzinga](https://www.benzinga.com/25/02/43560312/life-science-tools-firm-avantor-reports-mixed-q4-earnings-forecasts-organic-sales-growth-in-2025)
